Medicus Pharma Ltd. -29MDCXWPreferred / convertible
13F holders, Q1 2025 (March 31)7holders +1
2new positions
1sold out
$1.20avg. 13F price*
At the end of Q1 2025, 7 institutions reported holding Medicus Pharma Ltd. -29 (MDCXW) in their 13F filings, up 1 from Q4 2024. 2 opened new positions and 1 sold out. The largest holders were Anson Funds Management LP ($158K), Clear Street LLC ($46K) and Warberg Asset Management LLC ($46K).
- Company
- Medicus Pharma Ltd. -29
- CUSIP
- 58471K111
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $53K |
| Exits | 1 | $27K |
All 13F filers, Q4 2024 → Q1 2025: 137,901 shares bought and 41,300 shares sold, net +96,601 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| Anson Funds Management LP | — | No change | 42,400 | $158K |
| Clear Street LLC | — | Add +59.3% | 65,723 | $46K |
| Warberg Asset Management LLC | — | Add +136.7% | 65,019 | $46K |
| Armistice Capital, LLC | — | New | 60,600 | $42K |
| Private Advisor Group, LLC | — | New | 15,000 | $11K |
| Connective Capital Management, LLC | — | No change | 6,000 | $4K |
| UBS Group AG | — | Add +14.9% | 2,299 | $2K |
"% of holder's portfolio" is MDCXW's weight in each manager's 13F, not the share of Medicus Pharma Ltd. -29 the manager owns.